Evidence map›Paper›PMID 38076050›Full record

ReviewHeliyon2023

Usefulness of machine learning and deep learning approaches in screening and early detection of breast cancer.

Mohsen Ghorbian, Saeid Ghorbian

Abstract readReview
In one paragraph

Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohsen GhorbianDepartment of Computer Engineering, Qom Branch, Islamic Azad University, Qom, Iran.
Saeid GhorbianDepartment of Molecular Genetics, Ahar Branch, Islamic Azad University, Ahar, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is one of the most common types of cancer in women, and its prevalence is on the rise. The diagnosis of this disease in the first steps can be highly challenging. Hence, early and rapid diagnosis of this disease in its early stages increases the likelihood of a patient's recovery and survival. This study presents a systematic and detailed analysis of the various ML approaches and mechanisms employed during the BC diagnosis process. Further, this study provides a comprehensive and accurate overview of techniques, approaches, challenges, solutions, and important concepts related to this process in order to provide healthcare professionals and technologists with a deeper understanding of new screening and diagnostic tools and approaches, as well as identify new challenges and popular approaches in this field. Therefore, this study has attempted to provide a comprehensive taxonomy of applying ML techniques to BC diagnosis, focusing on the data obtained from the clinical methods diagnosis. The taxonomy presented in this study has two major components. Clinical diagnostic methods such as MRI, mammography, and hybrid methods are presented in the first part of the taxonomy. The second part involves implementing machine learning approaches such as neural networks (NN), deep learning (DL), and hybrid on the dataset in the first part. Then, the taxonomy will be analyzed based on implementing ML approaches in clinical diagnosis methods. The findings of the study demonstrated that the approaches based on NN and DL are the most accurate and widely used models for BC diagnosis compared to other diagnostic techniques, and accuracy (ACC), sensitivity (SEN), and specificity (SPE) are the most commonly used performance evaluation criteria. Additionally, factors such as the advantages and disadvantages of using machine learning techniques, as well as the objectives of each research, separately for ML technology and BC detection, as well as evaluation criteria, are discussed in this study. Lastly, this study provides an overview of open and unresolved issues related to using ML for BC diagnosis, along with a proposal to resolve each issue to assist researchers and healthcare professionals.

Indexed as

Breast cancerCancer detectionDeep learning (DL)Machine learning (ML)Magnetic resonance imaging (MRI)Mammography

Identifiers

PMID38076050
PMCPMC10709063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.